Biocon

388.25
-9.05
(-2.28%)
Market Cap
46,613.30
Eps
8.55
PE Ratio (TTM)
33.46
Dividend Yield
0.13
Industry
Healthcare
52 Week High
404.70
52 Week low
244.55
PB Ratio
2.22
Debt to Equity
0.91
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Biocon to Consider Fund Raising Through Commercial Papers3 days ago
Biocon Limited has announced that it will consider raising funds through the issuance of commercial papers or other private placement methods on January 27. This decision indicates the company's intent to secure additional capital, potentially for operational needs or strategic initiatives.
Growth Rate
Revenue Growth
35.25 %
Net Income Growth
101.84 %
Cash Flow Change
59.45 %
ROE
79.37 %
ROCE
103.31 %
EBITDA Margin (Avg.)
6.64 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
3,143
3,427
4,048
4,330
5,659
6,462
7,398
8,397
11,550
15,621
16,652
Expenses
2,394
2,580
2,912
3,294
4,121
4,697
5,490
6,214
8,663
11,457
11,781
EBITDA
749
847
1,137
1,035
1,538
1,765
1,907
2,183
2,888
4,164
4,871
Operating Profit %
23 %
23 %
25 %
20 %
25 %
25 %
23 %
24 %
22 %
22 %
20 %
Depreciation
221
249
277
385
448
552
715
814
1,113
1,569
1,647
Interest
9
29
26
62
71
65
58
68
419
974
955
Profit Before Tax
624
751
850
610
1,215
1,215
1,068
983
897
1,525
2,371
Tax
96
142
162
157
212
315
222
212
254
227
506
Net Profit
528
609
688
453
1,003
900
846
772
643
1,298
1,865
EPS in ₹
24.87
28.04
10.39
6.31
7.65
6.32
6.24
5.44
3.88
8.55
12.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
56,071
Fixed Assets
1,630
1,749
3,626
3,700
4,471
5,971
6,364
6,569
29,468
30,644
Current Assets
2,563
3,971
4,048
4,149
4,889
5,325
7,600
8,382
12,334
15,179
Capital Work in Progress
1,677
2,240
839
1,303
1,899
2,196
2,800
4,110
7,317
7,993
Investments
230
901
1,253
675
1,012
966
1,952
1,588
2,069
1,000
Other Assets
2,839
3,569
3,676
4,312
4,811
5,311
7,406
8,127
13,189
16,434
Total Liabilities
6,375
8,458
9,394
9,990
12,192
14,444
18,522
20,394
52,043
56,071
Current Liabilities
1,555
1,666
1,678
2,141
3,039
4,008
4,210
3,828
8,511
15,359
Non Current Liabilities
1,378
2,493
2,502
2,200
2,447
3,053
5,805
7,096
21,043
15,437
Total Equity
3,443
4,300
5,214
5,649
6,707
7,383
8,508
9,470
22,489
25,275
Reserve & Surplus
3,171
3,992
4,738
4,881
5,798
6,106
7,027
7,832
17,267
19,183
Share Capital
100
100
100
300
300
600
600
600
600
600

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-94
300
-47
-261
210
165
72
-243
641
-380
Investing Activities
-491
-1,138
-510
-684
-703
-1,505
-3,651
-1,662
-14,260
-1,002
Operating Activities
211
371
640
662
1,155
1,283
1,160
1,177
1,853
2,954
Financing Activities
186
1,068
-178
-240
-242
388
2,564
242
13,049
-2,333

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
60.67 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
60.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.96 %
6.55 %
5.63 %
5.90 %
5.93 %
5.66 %
DIIs
6.65 %
6.89 %
6.87 %
6.83 %
7.79 %
7.30 %
7.76 %
8.63 %
11.90 %
12.56 %
14.08 %
14.51 %
13.68 %
14.30 %
14.44 %
15.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.89 %
11.03 %
11.49 %
11.37 %
10.87 %
10.72 %
12.07 %
12.46 %
13.21 %
13.34 %
13.61 %
14.47 %
15.53 %
14.63 %
14.57 %
14.07 %
No of Share Holders
0
3,11,349
3,38,815
3,63,447
3,64,502
3,47,911
3,41,016
3,69,816
4,11,086
4,12,441
4,15,046
4,34,339
4,70,261
4,43,513
4,39,503
4,27,705

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 1 1 0.00 0.00 0.5 1.5 0.5 0.00
Dividend Yield (%) 0.00 1.01 0.33 0.37 0.00 0.00 0.25 0.57 0.13 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,822.20 4,37,206.80 39.00 49,887.20 12.06 9,648 27.34 52.99
5,762.60 1,52,978.90 83.37 8,184.00 0.89 1,600 46.55 42.89
1,411.40 1,13,986.60 24.70 26,520.70 14.17 4,155 12.95 34.38
3,248.40 1,09,940.60 63.16 10,785.70 11.59 1,656 13.54 46.39
2,506.90 1,03,426.40 50.64 10,615.60 19.57 1,942 -16.38 40.31
1,224.40 1,02,165.30 19.03 28,905.40 12.36 5,578 1.69 28.93
2,134.25 97,364.00 37.06 20,141.50 19.94 1,936 73.53 44.12
957.60 96,357.00 22.50 19,831.50 13.82 3,831 14.57 43.05
1,212.20 70,404.80 19.47 29,559.20 17.55 3,169 8.66 46.55
5,022.70 60,053.90 27.64 12,978.40 9.84 1,812 14.16 29.55

Corporate Action

Technical Indicators

RSI(14)
Neutral
56.23
ATR(14)
Less Volatile
13.16
STOCH(9,6)
Neutral
76.06
STOCH RSI(14)
Neutral
52.72
MACD(12,26)
Bullish
0.99
ADX(14)
Weak Trend
23.98
UO(9)
Bearish
54.96
ROC(12)
Uptrend And Accelerating
4.59
WillR(14)
Neutral
-35.19